These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 12386267

  • 1. A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic rats.
    Hirata M, Endo K, Ohkawa H, Kumaki K, Kubodera N, Slatopolsky E, Kurokawa K, Fukagawa M.
    Nephrol Dial Transplant; 2002; 17 Suppl 10():37-40. PubMed ID: 12386267
    [Abstract] [Full Text] [Related]

  • 2. Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.
    Takahashi F, Furuichi T, Yorozu K, Kawata S, Kitamura H, Kubodera N, Slatopolsky E.
    Nephrol Dial Transplant; 2002; 17 Suppl 10():46-52. PubMed ID: 12386269
    [Abstract] [Full Text] [Related]

  • 3. A comparison between 1,25-dihydroxy-22-oxavitamin D(3) and 1,25-dihydroxyvitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action.
    Hirata M, Endo K, Katsumata K, Ichikawa F, Kubodera N, Fukagawa M.
    Nephrol Dial Transplant; 2002; 17 Suppl 10():41-5. PubMed ID: 12386268
    [Abstract] [Full Text] [Related]

  • 4. Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol(2).
    Fan SL, Schroeder NJ, Calverley MJ, Burrin JM, Makin HL, Cunningham J.
    Nephrol Dial Transplant; 2000 Dec; 15(12):1943-9. PubMed ID: 11096138
    [Abstract] [Full Text] [Related]

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 6. In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3.
    Hirata M, Katsumata K, Endo K, Fukushima N, Ohkawa H, Fukagawa M.
    Nephrol Dial Transplant; 2003 Sep; 18(9):1770-6. PubMed ID: 12937223
    [Abstract] [Full Text] [Related]

  • 7. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
    Brown AJ, Ritter CR, Finch JL, Morrissey J, Martin KJ, Murayama E, Nishii Y, Slatopolsky E.
    J Clin Invest; 1989 Sep; 84(3):728-32. PubMed ID: 2760211
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D analogues for secondary hyperparathyroidism.
    Brown AJ, Dusso AS, Slatopolsky E.
    Nephrol Dial Transplant; 2002 Sep; 17 Suppl 10():10-9. PubMed ID: 12386264
    [Abstract] [Full Text] [Related]

  • 9. Abnormal calcaemic response to PTH in the uraemic rat without secondary hyperparathyroidism.
    Berdud I, Martin-Malo A, Almaden Y, Tallon S, Concepcion MT, Torres A, Felsenfeld A, Aljama P, Rodriguez M.
    Nephrol Dial Transplant; 1996 Jul; 11(7):1292-8. PubMed ID: 8672025
    [Abstract] [Full Text] [Related]

  • 10. Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.
    Akizawa T, Suzuki M, Akiba T, Nishizawa Y, Ohashi Y, Ogata E, Slatopolsky E, Kurokawa K.
    Nephrol Dial Transplant; 2002 Jul; 17 Suppl 10():28-36. PubMed ID: 12386266
    [Abstract] [Full Text] [Related]

  • 11. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
    Monier-Faugere MC, Geng Z, Friedler RM, Qi Q, Kubodera N, Slatopolsky E, Malluche HH.
    Kidney Int; 1999 Mar; 55(3):821-32. PubMed ID: 10027919
    [Abstract] [Full Text] [Related]

  • 12. Hyperphosphatemia modestly retards parathyroid hormone suppression during calcitriol-induced hypercalcemia in normal and azotemic rats.
    Jara A, Chacón C, Felsenfeld AJ.
    Nephron; 2002 Dec; 92(4):883-8. PubMed ID: 12399635
    [Abstract] [Full Text] [Related]

  • 13. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E, Canaff L, Fox J, Hendy GN.
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [Abstract] [Full Text] [Related]

  • 14. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.
    Hruby M, Ureña P, Mannstadt M, Schmitt F, Lacour B, Drüeke TB.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622
    [Abstract] [Full Text] [Related]

  • 15. Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients.
    Yasuda M, Akiba T, Nihei H.
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S108-11. PubMed ID: 12612965
    [Abstract] [Full Text] [Related]

  • 16. How dietary phosphate, renal failure and calcitriol administration affect the serum calcium-phosphate relationship in the rat.
    Jara A, Chacón C, Felsenfeld AJ.
    Nephrol Dial Transplant; 2002 May; 17(5):765-71. PubMed ID: 11981061
    [Abstract] [Full Text] [Related]

  • 17. Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study.
    Kurokawa K, Akizawa T, Suzuki M, Akiba T, Ogata E, Slatopolsky E.
    Nephrol Dial Transplant; 1996 May; 11 Suppl 3():121-4. PubMed ID: 8840326
    [Abstract] [Full Text] [Related]

  • 18. Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats.
    Szabó A, Freesmeyer MG, Abendroth K, Stein G, Rosivall L, El-Shakmak A, Ritz E.
    Eur J Clin Invest; 1999 Jun; 29(6):529-35. PubMed ID: 10354215
    [Abstract] [Full Text] [Related]

  • 19. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ.
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [Abstract] [Full Text] [Related]

  • 20. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
    Malberti F, Corradi B, Cosci P, Colecchia M, Leopardi O, Grossi L, Oldini C, Imbasciati E.
    Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.